ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,296.92
0.00%
Dow Jones
39,892.22
0.06%
US Dollar vs MXN
16.6296
-0.31%
Brent Oil
83.39
0.22%
Bitcoin
67,138.77
2.91%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Orchard Therapeutics PLC (ORTX)

  7. Orchard Therapeutics PLC (ORTX) Noticias

ORTX Orchard Therapeutics PLC

16.70
0.00 (0.00%)
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Orchard Therapeutics PLC ORTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 16.70 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
16.70
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/5/202406:00GLOBEOrchard Therapeutics Announces Multiple Presentations at..
03/5/202406:00GLOBEOrchard Therapeutics Co-founder and Chief Executive Officer..
20/3/202406:00GLOBEOrchard Therapeutics Outlines U.S. Launch Plans for..
18/3/202414:41GLOBEOrchard Therapeutics Receives FDA Approval of Lenmeldy™..
14/2/202420:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/2/202413:39EDGAR2Form 15-12G - Securities registration termination [Section..
05/2/202406:00GLOBEOrchard Therapeutics Announces First Patient Randomized in..
02/2/202406:00GLOBEOrchard Therapeutics Announces Multiple Presentations at the..
30/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
25/1/202406:00GLOBEOrchard Therapeutics Announces Agreement with the Beneluxa..
24/1/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:41EDGAR2Form S-8 POS - Securities to be offered to employees in..
24/1/202415:28EDGAR2Form POS AM - Post-Effective amendments for registration..
24/1/202415:17EDGAR2Form 8-K - Current report
24/1/202404:00GLOBEKyowa Kirin successfully completes acquisition of Orchard..
22/1/202415:10EDGAR2Form 8-K - Current report
19/12/202315:49EDGAR2Form 8-K - Current report
11/12/202306:00GLOBEOrchard Therapeutics Receives Swissmedic Approval for..
08/12/202315:39EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/12/202315:37EDGAR2Form 8-K - Current report
30/11/202315:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/11/202315:06EDGAR2Form 8-K - Current report
30/11/202306:00GLOBEOrchard Therapeutics Receives U.S. FDA Fast Track..
21/11/202306:53EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/11/202306:51EDGAR2Form 8-K - Current report
16/11/202315:45EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
13/11/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202306:05EDGAR2Form 8-K - Current report
13/11/202306:00GLOBEOrchard Therapeutics Reports Third Quarter 2023 Financial..
03/11/202316:11EDGAR2Form PREM14A - Preliminary proxy statements relating to..
26/10/202315:35EDGAR2Form 8-K - Current report
26/10/202306:00GLOBEOrchard Therapeutics Announces Presentation of Additional..
24/10/202306:00GLOBEOrchard Therapeutics Announces Multiple Presentations at..
17/10/202315:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/10/202316:26EDGAR2Form DEFA14C - Additional information statement materials,..
05/10/202315:48EDGAR2Form DEFA14C - Additional information statement materials,..
05/10/202315:45EDGAR2Form DEFA14C - Additional information statement materials,..
05/10/202315:43EDGAR2Form DEFA14C - Additional information statement materials,..
05/10/202315:40EDGAR2Form DEFA14C - Additional information statement materials,..
05/10/202308:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/10/202308:05EDGAR2Form 8-K - Current report
05/10/202306:19IHMARKETNEWSThursday’s Wall Street Highlights: Orchard Therapeutics,..
05/10/202302:35GLOBEKyowa Kirin to Acquire Orchard Therapeutics
18/9/202306:07EDGAR2Form 8-K - Current report
18/9/202306:00GLOBEOrchard Therapeutics Announces Acceptance of Biologics..
31/8/202306:00GLOBEOrchard Therapeutics Announces Presentation of Data..
21/8/202315:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/8/202316:04EDGAR2Form S-8 - Securities to be offered to employees in employee..

Su Consulta Reciente

NASDAQ
ORTX
Orchard Therapeutics
TSXV
TPO
BIT
INFL1
UBS ETF BBG Barc Euro In...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados